Inventor · disambiguated record
Avital Laxer
Also filed as: LAXER AVITAL
9 granted patents·9 pending applications·48 citations·filing 2006–2023
86Inventor score
Top patents by PatentIndex Score
18 records- 0193US7884208B2Crystals of laquinimod sodium, and process for the manufacture thereofTEVA PHARMA·Filed 2006·Granted Feb 8, 2011·27 cites·8 claims
- 0283US8580819B2Deuterated N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereofPIRYATINSKY VICTOR·Filed 2011·Granted Nov 12, 2013·9 cites·29 claims
- 0380US8673322B2Crystals of laquinimod sodium, and process for the manufacture thereofFRENKEL ANTON·Filed 2011·Granted Mar 18, 2014·4 cites·44 claims
- 0480US8647646B2Crystals of laquinimod sodium, and process for the manufacture thereofFRENKEL ANTON·Filed 2011·Granted Feb 11, 2014·4 cites·23 claims
- 0575US9233927B2Crystals of laquinimod sodium and improved process for the manufacture thereofFRENKEL ANTON·Filed 2014·Granted Jan 12, 2016·2 cites·22 claims
- 0663US8975279B2Amine salts of laquinimodFRENKEL ANTON·Filed 2013·Granted Mar 10, 2015·1 cites·20 claims
- 0762US2025243242A1Levodopa tyrosine polymorphsNEURODERM LTD·Filed 2023·Application pending·0 cites
- 0860US8809537B2N-ethyl-4-hydroxyl-1-methyl-5-(methyl(2,3,4,5,6-pentahydroxyhexyl)amino)-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamideLAXER AVITAL·Filed 2013·Granted Aug 19, 2014·1 cites·36 claims
- 0958US2014171647A1Crystals of laquinimod sodium, and process for the manufacture thereofFRENKEL ANTON·Filed 2014·Application pending·0 cites
- 1057US9102620B2Deuterated N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereofPIRYATINSKY VICTOR·Filed 2014·Granted Aug 11, 2015·0 cites·20 claims
- 1155US2024207410A1Stabilized liquid compositions comprising a levodopa-tyrosine conjugate and uses thereofNEURODERM LTD·Filed 2022·Application pending·0 cites
- 1253US2014051723A1Deuterated n-ethyl-n-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, salts and uses thereofTEVA PHARMA·Filed 2013·Application pending·0 cites
- 1352US2017327464A1Crystals of laquinimod sodium and improved process for the manufacture thereofFRENKEL ANTON·Filed 2017·Application pending·0 cites
- 1448US9284276B2N-ethyl-N-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereofIOFFE VLADIMIR·Filed 2013·Granted Mar 15, 2016·0 cites·17 claims
- 1548US2016158216A1Crystals of laquinimod sodium and improved process for the manufacture thereofFRENKEL ANTON·Filed 2015·Application pending·0 cites
- 1642US2017065576A1N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereofIOFFE VLADIMIR·Filed 2016·Application pending·0 cites
- 1740US2016151345A1N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereofIOFFE VLADIMIR·Filed 2016·Application pending·0 cites
- 1840US2016151346A1N-ethyl-n-phenyl-1,2-dihydro-4,5-di-hydroxy-1-methyl-2-oxo-3-quinolinecarboxamide, preparation and uses thereofIOFFE VLADIMIR·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Avital Laxer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →